AU2001273497A1 - Use of IL-8 receptor antagonists in the treatment of virus infections - Google Patents

Use of IL-8 receptor antagonists in the treatment of virus infections

Info

Publication number
AU2001273497A1
AU2001273497A1 AU2001273497A AU7349701A AU2001273497A1 AU 2001273497 A1 AU2001273497 A1 AU 2001273497A1 AU 2001273497 A AU2001273497 A AU 2001273497A AU 7349701 A AU7349701 A AU 7349701A AU 2001273497 A1 AU2001273497 A1 AU 2001273497A1
Authority
AU
Australia
Prior art keywords
viral infection
human
respiratory viral
therapeutic agent
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273497A
Other languages
English (en)
Inventor
Susan B. Dillon
Susan B. Dillon
Ruth Tal-Singer
Ruth Talsinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001273497A1 publication Critical patent/AU2001273497A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001273497A 2000-07-18 2001-07-16 Use of IL-8 receptor antagonists in the treatment of virus infections Abandoned AU2001273497A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18
US60219053 2000-07-18
PCT/US2001/022328 WO2002005814A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Publications (1)

Publication Number Publication Date
AU2001273497A1 true AU2001273497A1 (en) 2002-01-30

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273497A Abandoned AU2001273497A1 (en) 2000-07-18 2001-07-16 Use of IL-8 receptor antagonists in the treatment of virus infections

Country Status (17)

Country Link
EP (1) EP1307190A4 (ja)
JP (1) JP2004509852A (ja)
KR (1) KR20030019587A (ja)
CN (1) CN1449285A (ja)
AR (1) AR033830A1 (ja)
AU (1) AU2001273497A1 (ja)
BR (1) BR0112603A (ja)
CA (1) CA2418162A1 (ja)
CZ (1) CZ2003132A3 (ja)
HU (1) HUP0300754A3 (ja)
IL (1) IL153921A0 (ja)
MX (1) MXPA03000500A (ja)
NO (1) NO20030201L (ja)
NZ (1) NZ523659A (ja)
PL (1) PL365886A1 (ja)
WO (1) WO2002005814A1 (ja)
ZA (1) ZA200300474B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
CN107072976A (zh) * 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 用于治疗传染性疾病的包含Danirixin的药物组合物
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
WO2021191305A1 (en) * 2020-03-26 2021-09-30 Dompe' Farmaceutici Spa Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
AU3539795A (en) * 1994-08-25 1996-03-14 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
SE9802729D0 (sv) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (sv) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
CZ2003132A3 (cs) 2003-09-17
CN1449285A (zh) 2003-10-15
EP1307190A1 (en) 2003-05-07
CA2418162A1 (en) 2002-01-24
HUP0300754A3 (en) 2009-03-02
BR0112603A (pt) 2004-08-24
JP2004509852A (ja) 2004-04-02
AR033830A1 (es) 2004-01-07
NZ523659A (en) 2006-01-27
KR20030019587A (ko) 2003-03-06
NO20030201D0 (no) 2003-01-15
WO2002005814A1 (en) 2002-01-24
EP1307190A4 (en) 2007-08-22
HUP0300754A2 (hu) 2003-08-28
ZA200300474B (en) 2004-08-17
PL365886A1 (en) 2005-01-10
IL153921A0 (en) 2003-07-31
NO20030201L (no) 2003-03-17
MXPA03000500A (es) 2003-06-24

Similar Documents

Publication Publication Date Title
AU763573B2 (en) Thiadiazolyl urea or thiourea derivatives for antiviral treatment
US6214881B1 (en) IL-8 receptor antagonists
JP3306830B2 (ja) レトロウイルスインテグラーゼの阻害剤
WO1997035572A1 (en) Carboxylic acid indole inhibitors of chemokines
EP1165077B1 (en) Viral treatment
US20040038854A1 (en) Use of il-8 receptor antagonists in the treatment of virus infections
US20060122173A1 (en) Il-8 receptor antagonists
AU2001273497A1 (en) Use of IL-8 receptor antagonists in the treatment of virus infections
US20040022762A1 (en) Use of il-8 protein modulators in the treatment of viral infections
AU744492B2 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
EP1180028B1 (en) Il-8 receptor antagonists
US6335352B1 (en) IL-8 receptor antagonists
US6248785B1 (en) IL-8 receptor antagonists
JP2000515495A (ja) Ｉｌ―８レセプターアンタゴニスト
CA2368647A1 (en) Viral treatment
AU767000B2 (en) IL-8 receptor antagonists
EP1185270A1 (en) Il-8 receptor antagonists
JPH0684300B2 (ja) インターロイキン―１生合成の阻止剤としての３―置換―２―オキシインドール誘導体
MXPA01009889A (en) Thiadiazolyl urea or thiourea derivatives for antiviral treatment
MXPA00002283A (en) Il-8 receptor antagonists
MXPA99001533A (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application